Surrogate Endpoints Guidance: New International...

By João L. Carapinha

January 24, 2025

The National Institute for Health and Care Excellence (NICE) published a new report
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
Transforming Africa through Healthcare Biotechnology Innovation
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Canada’s Drug Agency Launches Consultation on New Methods Guide for Hea...
NICE’s Position on AI in Evidence Generation
CHEERS-AI Economic Evaluation
HIQA’s Strategic Blueprint for Health Care Excellence: Draft Corporate ...
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Enhancing Global Health through Regulatory Collaboration
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
Thailand’s Healthcare System and the Role of HTA: A Model of Universal ...